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Abstract
Aortic valve stenosis is a common valvular heart disease and its incidence is 
increasing day by day as the life expectancy is increasing gradually. It can be of 
congenital or acquired variety but in old ages aortic stenosis is acquired mostly and 
main reasons rheumatic heart disease or senile calcification of aortic valve. Aortic 
valve replacement with mechanical tissue valves is the surgical management of 
aortic valve stenosis but some of the patients are not suitable for the surgery based 
on their physical status and associated comorbidities. These patients are high risk 
for surgical complications or they have prohibitive risks for surgery. Transcutaneous 
aortic valve implantation is the new technique developed to implanting aortic valve 
mostly without opening the sternum and without using cardiopulmonary bypass 
machine. This procedure is mostly done via transfemoral access but in case of con-
traindications to use femoral artery for access some other different accesses are used 
to implant the aortic valve, that is, transsubclavian/transaxillary access, transapical 
access, transaortic access, transcarotid and transcaval accesses. In this chapter we 
are going to discuss all accesses in details.
Keywords: TAVI, transfemoral access, transsubclavian access, transaxillary access, 
transapical access, transaortic access, transcarotid and transcaval access
1. Introduction
Aortic valve is present between left ventricle and aorta. It opens during ventricu-
lar systole and closes at ventricular diastole.
Aortic stenosis (AS) represents obstruction of blood flow across the aortic valve 
due to congenital or acquired narrowing. Etiology can be bicuspid aortic valve, 
rheumatic aortic stenosis and senile aortic stenosis due to calcification of aortic 
valve.
It is a progressive disease that presents after a long subclinical period with 
symptoms of decreased exercise capacity, exertional chest pain (angina), syncope, 
and heart failure.
Echocardiography helps in diagnosis and grading of the aortic stenosis 
(Table 1).
Most of the patients usually undergo open surgical aortic valve replacement with 
mechanical or bioprosthetic aortic valve, but some patients may not be suitable 
Vascular Access Surgery - Tips and Tricks
2
candidate for the open surgical aortic valve replacement because of their associated 
comorbidities or risk of adverse outcome.
Transcatheter aortic valve implantation (TAVI) is the procedure of implanting 
the prosthetic aortic valve through intravascular route. First transcatheter aortic 
valve implantation was done by Cribier et al. [1].
It is the preferred procedure for the severe aortic stenosis patients who are being 
considered as non-operable [2] or high risk procedure [3] for open surgical aortic 
valve replacement.
It has become a well-established procedure over the years and since its invention 
over hundreds of thousands of valves has been deployed. This number is gradually 
increasing day by day.
There is a basic idea of a crimped aortic bioprosthetic valve and its transcatheter 
implantation in aortic valve position.
Followings (Table 2) are the aspects to be considered by the heart team to take 
decision for management of severe aortic stenosis in high risk patients for surgical 
aortic valve replacement or TAVI.
There are many ways of implanting the aortic valve (Figure 1) by TAVI but 
most commonly used route is retrograde transfemoral arterial access. This is less 
invasive and the only percutaneous way of implanting the aortic valve. Even it can 
be done without general anesthesia. Other routes need surgical cut down for the 
arterial access.
Peripheral vessels must be assessed for the size, tortuosity, and calcification of 
the iliac and femoral arteries. Vascular assessment is most commonly performed 
using contrast angiography or CT angiography. By default transfemoral access is 
considered to be vascular access site for TAVI.
Other retrograde transcatheter aortic valve implantation (TAVI) is currently 
performed through an alternative access in 15% of patients. Existing data does 
not favor one route over another one. All the routes have different advantages and 
disadvantages.
This chapter will review the different accesses for aortic valve implantation.
Most common vascular access for TAVI is transfemoral artery by default. As the 
technology has improved, the options for the vascular access for TAVI has increased 
and may include transfemoral, transsubclavian (transaxillary), transapical, trans-
aortic, and transcaval.
With the availability of the lower profile aortic valves for implantation, these 
valves are mostly deployed via transfemoral route but in case of contra-indication 
to use femoral artery for TAVI other vessels are used for access; as in case femoral 
arteries are of small size, tortuous or heavily calcified.
Before proceeding for TAVI, patient should undergo full work up with coronary 
angiography, CT angiography scan of heart, aorta and peripheral vessels, transtho-
racic and transesophageal echocardiography, lab investigations and other radiologi-
cal investigations.
Table 1. 
Grading of aortic stenosis.
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Table 2. 
Factors to be considered in severe Aortic stenosis in high risk patients for Surgical AVR or TAVI.
Figure 1. 
Different routes of aortic valve implantation by TAVI.
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Although in most of the TAVI procedures, Cardiopulmonary bypass (CPB) is not 
required but patient should have a full informed consent with possibility of emer-
gency midline sternotomy and use of CPB in case of complications.
While it is difficult to predict which patients will need temporary CPB support 
during or after valve deployment, usually patients with ejection fraction (<25%) 
with severe pulmonary hypertension, especially those requiring significant inotro-
pes during and after anesthetic induction are at higher risk.
2. Preoperative assessment and planning
Potential TAVI patients must undergo full evaluation with
• Coronary angiography
• Transthoracic echocardiography (TTE)
• Transesophageal echocardiography (TEE)
• Cardiac computed tomography
• CT angiography of aorta and peripheral vessels
Initial TAVI evaluation should include an assessment of the following 
variables also:
1. Severity of aortic stenosis.
2. Anatomy of the aortic valve.
3. Aortic valve calcification.
4. Annular, sinotubular, and sinus of Valsalva dimensions.
5. Ventricular function.
6. Coronary artery disease.
7. Height of coronary ostia from aortic annulus.
8. Ileofemoral vessel size, calcification, and tortuosity.
Patients with severe coronary artery disease and lesions which are treatable by 
percutaneous coronary intervention should get stents prior to the procedure. We 
keep patients on dual anti platelets therapy for about 6 weeks and then take them 
for TAVI.
The aortic annulus is sized at mid-systole, and the valve size is selected based 
upon 10% over-sizing of the annular diameter.
If the annulus is not adequately sized, there would be risk of improper valve 
size selection that could lead to paravalvular leak, valve embolization, coronary 
obstruction if the sinus of Valsalva is small or the distance between the annulus and 
the coronary ostia is less (<10 mm).
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3. Transfemoral access
3.1 Introduction
Transfemoral access (Figure 2) is the most preferred route in majority of the 
TAVI procedures world over [4] unless there is an increased risk of vascular compli-
cations depending on vascular size, tortuosity and calcification [5].
3.2 Planning
• All patients should undergo a CT-angiographic scan with 3D reconstruction of 
aorta and femoral vessels
• Aorta should be assessed for tortuosity, presence of aneurysms, atherosclerotic 
plaques and aortic arch calcifications
• Minimum size of femoral and iliac arteries should be more than 5.5 mm (ide-
ally more than 6.5 mm) and it should be free of calcification
• A circumferential calcification could be a potential contraindication for 
transfemoral approach
• Some studies shown that a sheath to femoral artery ratio of greater than 1.05 is 
predictive of a vascular complication [6]
• Bifurcation of femoral artery and its relation with the femoral head should be 
evaluated properly
• Site of needle entry may be altered based on CT scan or ultrasound findings 
of high bifurcation of the common femoral artery and presence of significant 
calcium.
Figure 2. 
Transfemoral access for TAVI.
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3.3 Technique
• Patient lies supine on operating table
• Endotracheal intubation, arterial line and central line with temporary pace 
maker lead through right internal jugular vein and placed
• Surgical part painted and draped from neck down till mid-thigh
• Femoral arteries are accessed percutaneously under vascular ultrasound or 
fluoroscopic guidance
• Surgical cut down can be considered in obese patients with deep femoral arteries
• 6Fr sheath is inserted in one femoral artery and then a 5 Fr pigtail catheter is 
placed in non-coronary sinus of aorta as a marker for aortic valve placement 
and positioning.
• These days routinely we are using right radial artery for placing Pigtail catheter 
in non-coronary sinus of aorta instead of femoral artery
• IV heparin is given to keep activated clotting time (ACT) around 200–250 s.
• Another femoral artery is used to insert 18 Fr valve deployment sheath. First a 
6 Fr sheath is inserted and then a soft, J-tipped wire is placed into the descend-
ing thoracic aorta (DTA).
• Two percutaneous sutures based vascular closure devices (Per close devices) 
are placed, which are used to control the bleeding after the procedure.
• The soft J-tipped wire and an exchange catheter are inserted into the aorta
• A soft wire is exchanged for a super-stiff Amplatz wire
• Then catheter and 6-Fr sheath are removed
• 18 Fr sheath is inserted after making a small nick with 11 blade at the puncture 
site in order to facilitate entry of bigger sheath
• Valve deployment is done through the 18-Fr sheath
• Contra lateral pigtail catheter should be pulled out a little before the opening 
the valve fully; to prevent the entrapment of the pigtail catheter in device
• Rapid ventricular pacing is done to decrease the blood pressure and valve is 
deployed under fluoroscopic and transesophageal echocardiographic guidance
• At completion of the procedure we reverse the ACT by giving protamine and then 
remove the deployment sheath first and control bleeding by per close devices.
• In case of doubtful control of bleeding or suspicion of femoral artery stenosis, 
we do check angiography using cross over from the contralateral femoral artery
• We usually extubate the patient in operating room
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4. Transsubclavian/axillary access
4.1 Introduction
The subclavian artery has recently become a site of access for TAVI [7]. Right 
axillary or subclavian artery is rarely used for TAVI because of anatomic restric-
tions and unfavourable angle for valve implantation. The proximal third of the left 
axillary artery (between the lateral border of the first rib and the medial border of 
the pectoralis minor) represents the ideal target for both surgical and percutaneous 
approaches.
A study suggested that subclavian access is not advisable in patients with subcla-
vian artery diameter <7 mm, significant tortuosity, or prior coronary artery bypass 
grafting (CABG) and patent in situ internal mammary artery grafts [8].
4.2 Disadvantages
There is a higher risk of stroke due to interruption of blood flow to the vertebral 
arteries in patients with carotid disease who depend on the vertebral arteries for 
cerebral perfusion.
4.3 Planning
• CT angio scan with 3D reconstruction of the subclavian and axillary arteries.
• Vessel size should be >6.5 mm without calcifications and tortuosity
• It is more prone for vascular complications (especially in old age) because of 
anatomical differences between subclavian/axillary (more elastic fibers and 
less muscular wall) and femoral arteries.
• Post CABG patients in whom LIMA was used for LAD anastomosis, this 
approach can be lethal due to acute graft occlusion.
4.4 Technique
• A femoral artery and vein access is obtained, 6 Fr sheath is inserted and then 
pigtail catheter is placed in the aortic sinus and a femoral transvenous tempo-
rary pacing lead inserted through femoral vein.
• Surgical cutdown for the left axillary artery is done in deltopectoral groove 
(6–7 cm in size and 1 cm below and parallel to the clavicle from the mid 
clavicular line to the axillary line) (Figure 3)
• Axillary artery is exposed by dissection of pectoralis major and lateral retrac-
tion of the pectoralis minor
• Purse string suture is placed on the artery
• The patient is heparinized to maintain an ACT 200–250 s
• A sheath is inserted by direct puncture Using the Seldinger technique
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• In some selected cases an 8–10 mm sized Dacron graft can be anastomosed in 
an end-to-side fashion and then cannulated with the valve deployment sheath
• A fully percutaneuos approach was described in 2012 as the “Hamburg Sankt 
George Approach” [9]
• Once the sheath is in place, aortic valve is deployed in same manner as for previ-
ously described transfemoral access
• Heparin reversal, sheath removal and control of vascular bleeding are done in 
same way as transfemoral approach.
5. Transapical access
5.1 Introduction
Transapical access (Figure 4) is the alternative approach for TAVI in patients in 
whom transfemoral or transsubclavian/transaxillary approach is not feasible.
Figure 4. 
Transapical access for TAVI.
Figure 3. 
Transsubclavian artery access.
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5.2 Advantages
The transapical approach has the following advantages over other approaches:
1. Peripheral vascular anatomy and size are not limitation
2. The valve is easily crossed in the antegrade direction (vs. retrograde)
3. Less paravalvular leaks
4. Shorter time for insertion and lesser contrast use
5.3 Disadvantages
1. Longer recovery due to thoracotomy
2. Bleeding
3. Not suitable for patients with significant lung disease (forced expiratory 
volume in 1 s <35%) or low ejection fraction (<15–20%) [10]
4. It could be a source of postoperative Left ventricular (LV) pseudoaneurysm, 
and may impair left ventricular function
5.4 Planning
• Preoperative CT scan chest is needed to identify both the rib space over the 
apex of the heart and the distance from the sternum to the LV apex
• CPB should be standby, to use in case of emergent conversion to open AVR
• Cannulation sites for CPB must be planned
• Common femoral artery and vein are used for cannulation usually
• Access to femoral vessels must be done in beginning of case, if femoral vessels 
are supposed to be used as a bailout CPB cannulation (on the contra lateral 
side, other than from the femoral arterial access for pigtail aortogram and 
venous access for ventricular pacing
• Axillary artery can also be cannulated in case femoral artery is small in size
• A final bailout for CPB is transapical cannulation itself putting a long arterial 
cannula across the aortic valve. The obvious advantage of this approach is that 
area will already be readily accessible. The disadvantage of the transapical CPB 
cannulation is that it gives up the site of access for valve deployment
• It need to be careful while tying the sutures as LV can tear due to friable 
myocardium
5.5 Technique
• It is done under general anesthesia
• The procedure should be performed in a hybrid operative room
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• Supine position with both arms tucked at the sides and a small roll under the 
left chest
• It is important to prep patient widely to include all potential CPB cannulation 
sites and for an antero lateral thoracotomy
• Femoral artery and vein access is achieved as routinely
• A femoral transvenous pacing lead is inserted in right ventricle and a pigtail 
catheter is placed in aortic root via femoral artery
• Anterolateral thoracotomy is made in the fifth or sixth intercostal space
• Dissection is carried down to the pleura and a rib retractor is placed
• After identifying the phrenic nerve, the pericardium is opened
• In cases of a previous sternotomy, adhesions are released between the pericar-
dium and epicardium for adequate exposure of the LV apex
• Two apical concentric pledgeted 3–0 PROLENE purse-string sutures are placed 
just cephalad to the apex and lateral to the LAD coronary artery
• The purse-string sutures must be deep into the myocardium as they are prone 
to tear through the ventricular tissue.
• The patient is heparinized to maintain an ACT 200–250 s
• Fluoroscopy is used to align all three aortic cusps in the same plane asin 
transfemoral approach
• The Left ventricle is punctured with a needle and a 0.035″ J wire is passed into 
the LV, across the aortic valve and into the ascending aorta
• The needle is exchanged for a 7-French sheath
• The 0.035″ guide wire is then exchanged for an Amplatz super-stiff wire
• The 7-French sheath is exchanged for the appropriate transapical delivery 
sheath
• If there is bleeding around the sheath, the purse-string sutures can be snared
• The bioprosthetic valve is delivered through the sheath and positioned 
across the aortic valve
• The valve is aligned parallel to the long axis of the aorta and perpendicular to 
the aortic annulus [11]
• Both transesophageal echocardiography (TEE) and aortic root angiogram 
under fluoroscopy are used to confirm the position of the valve
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• Once the optimal position is confirmed, the valve is deployed during rapid 
ventricular pacing
• The valve delivery apparatus is then removed leaving the stiff wire across the 
bioprosthesis
• TEE and angiography are used to assess valve position and paravalvular leak
• Balloon dilation may be performed if there is ≥2+ paravalvular leak
• Once satisfactory valve function and position is confirmed, all catheters and 
wires are removed from the apex, and purse-string sutures are tightened dur-
ing rapid ventricular pacing
• Protamine is given, and additional pledgeted sutures may be placed for 
adequate hemostasis
• The pericardium can be closed partially and a flexible Blake drain is placed in 
the left pleural space with part of it in the pericardium as well for the drainage
• Thoracotomy wound is closed in layers.
6. Transaortic access
6.1 Introduction
The transaortic approach was originally reported by Bapat et al. [12, 13]. The 
concept behind this first report was the use of the short transapical TAVI delivery 
system for the retrograde TAVI implant through the ascending aorta. Since then it 
has become a valid option in case of severe peripheral vascular disease [14].
6.2 Advantages
It has many practical advantages compared to other approaches:
1. It avoids thoracotomy which could potentially impedes pulmonary function in 
COPD patients
2. It avoids cannulation of the left ventricular apex
3. It is easier to achieve hemostasis in aorta than in LV due to fragile myocardium
4. If needed, direct visualization of the aorta permits rapid cannulation and 
initiation of cardiopulmonary bypass for support
6.3 Disadvantages
1. It is technically challenging in case of previous sternotomy and internal mam-
mary artery or saphenous vein grafts for CABG
2. It cannot be used in patients with porcelain aorta [15]
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6.4 Planning
• Preoperative CT scan is done to shows the relationship of the distal ascending 
aorta to the sternum, calcification, and the distance from the distal aortic can-
nulation site to the aortic root
• This distance should be ideally >7 cm allowing enough space for the valve 
implantation.
• CPB should be standby for any intra operative complication
6.5 Technique
• It needs a hybrid operating room where fluoroscopy and TEE
• Supine position with the lower neck remaining exposed for a counter incision 
for the delivery sheath
• Femoral arterial access is obtained as routine for placing a pigtail catheter in 
the aortic sinus
• A femoral transvenous pacing lead is placed in the right ventricle
• It can be performed by two approaches. The first is through mini-sternotomy 
(Figure 5) and the second is by a right mini-thoracotomy (Figure 6).
• An upper ministernotomy is performed with extension to the second intercos-
tal space, where the “J” is completed
• The pericardium is opened
• Pericardial stay sutures are placed for retraction. The aorta is then inspected to 
find a suitable place for catheter insertion
• It should be free from calcification and at least 6–8 cm from the aortic valve for 
valve deployment
• Two aortic purse strings are placed
Figure 5. 
Transaortic access by upper “J” ministernotomy forTAVI.
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• The patient is heparinized to maintain an ACT 200–250 s
• An 18-gauge needle with a 0.035″ soft J guide wire is passed through the 
counter incision in the lower neck and used to puncture the aorta through the 
purse strings
• The needle is exchanged for a 7-F sheath, and a multipurpose catheter with a 
straight soft wire is used to cross the valve
• This is exchanged for a 0.035″ Amplatz extra-stiff J wire
• The appropriate valve sheath is placed 2–4 cm into the aorta
• An aortic root aortogram is performed to align all the three leaflets of the aortic 
valve in same plane
• The valve is placed through the delivery sheath and positioned across the valve
• Once optimal positioning of the valve is confirmed, rapid ventricular pacing at 
160–200 beats/min is started
• When the valve is positioned correctly, the valve is deployed
• Aortograms and TEE is used to assess position and presence of any paravalvu-
lar leaks and patency of coronary ostia
• After full assessment, all catheters and wires are removed and the aortic 
sutures are tightened
• Protamine is administered
• A small flexible chest tube is placed in the mediastinum
• Sternum is closed with stainless steel wires
• A right mini-thoracotomy (through second intercostal space) is an option if 
a surgeon wants to avoid sternotomy or improve visualization in the case of a 
horizontal or a right-sided aorta
Figure 6. 
Transaortic right anterior minithoracotomy for TAVI.
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7. Transcarotid approach
7.1 Introduction
This approach is used rarely and required in only for the patients who have 
contraindications to all other accesses. Modine reported a successful series of 12 
patients who underwent CoreValve TAVI with no access site complications, no 
stroke, and only 1 TIA contralateral to the accessed side [16].
Mylotte et al. [17] reported the feasibility and the safety of this transcarotid 
approach in 96 patients enrolled in 3 different French sites. In their series, no major 
bleedings nor vascular complications related to the access site occurred, while only 
three transient ischemic attacks and no strokes were reported.
7.2 Planning
• Common carotid artery diameter must be >8 mm without any calcification, 
stenosis or tortuosity
• CT angio carotid and brain to rule out significant atherosclerotic disease and to 
assess patency of the circle of Willis and cerebral circulation
• MRI brain is done assess the patency of circle of Willis.
7.3 Technique
• A 6-F sheath is placed in the femoral artery and an angled pigtail catheter is 
utilized for ascending aortography
• A transvenous pacing lead is placed via the femoral vein
• The right common carotid artery is exposed by vertical lower neck incision
• After proximal cross-clamping of the common carotid artery, it is opened 
longitudinally for 2.5 cm
• The de-aired bypass shunt is placed through the arteriotomy into the distal 
carotid to maintain cerebral perfusion
• Cerebral oximetry is monitored for both the cerebral hemispheres during the 
whole procedure
• Through the proximal portion of the arteriotomy, a 0.035-inch J-tipped wire 
and 7-F introducer are placed in the ascending aorta
• A multipurpose catheter is then inserted and a straight wire is used to cross the 
aortic valve
• The straight wire is exchanged for an Amplatz extra-stiff wire
• Under TEE and fluoroscopic guidance bioprosthetic valve is deployed as in 
other approaches
• After the procedure the wires, catheters, and sheath are removed, and the 
carotid artery is repaired with a pericardial patch.
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8. Transcaval approach
8.1 Introduction
The transcaval approach, described by Greenbaum et al. [18] is considered as the 
last resort in patients not qualifying for any other vascular access. In the transcaval 
approach (Figure 7), the delivery system is inserted through the femoral vein and 
crossed to the arterial system by creating an aortocaval fistula, which is closed with 
an Amplatzer device after the valve is deployed.
A case series demonstrated the feasibility of the transcaval TAVI, revealing a 
successful valve deployment in 17 of 19 patients despite a 79% rate of transfusion 
and a 33% rate of vascular complications [18].
8.2 Planning
The location of the fistula is determined by a careful evaluation of the CT abdo-
men and pelvis prior to the procedure.
8.3 Technique
• A baseline CT-scan to identify a calcium free target on the right abdominal 
aortic wall allowing for a safe passage from the inferior vena cava to the aortic 
lumen of the large bore sheath
• After having obtained a femoral venous access, the inferior vena cava is 
punctured by means of a stiff CTO wire mounted over a microcatheter and a 
standard RCA or IMA guiding catheter
• The caval and aortic walls are perforated by using electrocautery applied at the 
distal end of the wire.
• Once the access is obtained to the aortic lumen, the wire is snared and both the 
microcatheter and the guiding catether are advanced into the abdominal aorta.
Figure 7. 
Transcaval access for TAVI.
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• This allows for the placement of a stiff “0.035” wire and the advancement of a 
large introducer sheath from the femoral vein into the aortic lumen for conven-
tional retrograde aortic valve replacement
• At case completion, heparin is reversed, and the aortic perforation is closed 
using a conventional vascular, duct or ventricular septal defect occluder device.
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